Something has seemed wrong since, let’s say, some time in 2016. Whatever your political, economic, or religious affiliations, there’s no denying our world has veered down a polarized path in the last ...
Joachim Trier goes deep into the silent ending of his Oscar contender, breaking down how he constructed a script that built toward such a powerful moment. “I’m out on a limb with this one,” said Trier ...
Netflix's new show The Abandons has a true cliffhanger ending, and we're here to break it down. One of the love stories of the season does get a (kind of) resolution. Did [SPOILER] and [SPOILER] ...
Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
IT: Welcome to Derry Episode 5 ends with a development that should send chills down any hardcore Stephen King fan’s spine. It’s not enough that our heroes finally visited the house on Neibolt Street ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results